Sviatchenko V A, Kiselev N N, Ryzhikov A B, Bulychev L E, Mikriukova T P, Netesov S V
Vopr Virusol. 2000 Nov-Dec;45(6):38-41.
Immunogenicity of recombinant vaccinia virus strain (VR26) expressing Venezuelan equine encephalomyelitis (VEE) virus structural protein genes was studied by oral immunization. Sera of animals immunized with VR26 contained antibodies specific to VEE virus, among which antibodies with virus-neutralizing activity were present. Evaluation of the protective efficiency of oral immunization with VR26 demonstrated a high level of animal protection from lethal doses of VEE virus. Rabbits immunized orally were highly resistant (protection index 142.9) to intranasal infection, which is of priority importance for antiVEE vaccine. Comparative analysis of the results of scarification and oral immunization with VR26 indicates that the type of immune response depends on the method of immunization. These results demonstrate good prospects of oral vaccination with recombinant VR26 strain for immunoprophylaxis of VEE.
通过口服免疫研究了表达委内瑞拉马脑炎(VEE)病毒结构蛋白基因的重组痘苗病毒株(VR26)的免疫原性。用VR26免疫的动物血清中含有VEE病毒特异性抗体,其中存在具有病毒中和活性的抗体。对用VR26进行口服免疫的保护效率评估表明,动物对致死剂量的VEE病毒具有高水平的保护。口服免疫的兔子对鼻内感染具有高度抵抗力(保护指数142.9),这对于抗VEE疫苗至关重要。对用VR26划痕免疫和口服免疫结果的比较分析表明,免疫反应类型取决于免疫方法。这些结果表明,用重组VR26株进行口服疫苗接种对VEE免疫预防具有良好前景。